PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-3.47%
Negative revenue growth while AVGO stands at 7.51%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-6.47%
Negative gross profit growth while AVGO is at 7.73%. Joel Greenblatt would examine cost competitiveness or demand decline.
-11.63%
Negative EBIT growth while AVGO is at 22.15%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-11.39%
Negative operating income growth while AVGO is at 22.15%. Joel Greenblatt would press for urgent turnaround measures.
-11.53%
Negative net income growth while AVGO stands at 330.61%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-10.81%
Negative EPS growth while AVGO is at 330.00%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-11.56%
Negative diluted EPS growth while AVGO is at 325.00%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
-0.11%
Share reduction while AVGO is at 0.34%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-0.11%
Reduced diluted shares while AVGO is at 3.54%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
4.58%
Dividend growth above 1.5x AVGO's 0.96%. David Dodd would verify if the firm's cash flow is robust enough for these payouts.
15.36%
OCF growth 1.25-1.5x AVGO's 12.92%. Bruce Berkowitz would see if superior pricing or efficient operations explain the gap.
93.75%
FCF growth above 1.5x AVGO's 14.42%. David Dodd would verify if the firm’s strategic investments yield superior returns.
40.67%
10Y revenue/share CAGR under 50% of AVGO's 379.83%. Michael Burry would suspect a lasting competitive disadvantage.
22.37%
5Y revenue/share CAGR under 50% of AVGO's 106.45%. Michael Burry would suspect a significant competitive gap or product weakness.
-15.98%
Negative 3Y CAGR while AVGO stands at 67.49%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
80.26%
10Y OCF/share CAGR under 50% of AVGO's 698.46%. Michael Burry would worry about a persistent underperformance in cash creation.
16.53%
Below 50% of AVGO's 91.80%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
-14.12%
Negative 3Y OCF/share CAGR while AVGO stands at 39.70%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
67.62%
Below 50% of AVGO's 1638.73%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
15.21%
Below 50% of AVGO's 333.15%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
-42.90%
Negative 3Y CAGR while AVGO is 91.90%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
86.70%
Below 50% of AVGO's 1032.87%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
94.14%
5Y equity/share CAGR at 50-75% of AVGO's 129.97%. Martin Whitman would question a shortfall in capital accumulation vs. the competitor.
28.44%
Below 50% of AVGO's 139.07%. Michael Burry suspects a serious short-term disadvantage in building book value.
299.73%
Below 50% of AVGO's 1564.74%. Michael Burry might see weaker long-term distribution growth, raising questions about the firm's capital allocation.
50.84%
5Y dividend/share CAGR at 50-75% of AVGO's 99.96%. Martin Whitman might see a lagging policy in mid-term shareholder returns.
18.30%
Below 50% of AVGO's 40.47%. Michael Burry suspects the firm invests elsewhere or can’t match the competitor’s dividend policy.
-7.68%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
5.38%
We show growth while AVGO is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
0.53%
Positive asset growth while AVGO is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
-2.01%
We have a declining book value while AVGO shows 2.74%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
-6.71%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
-0.20%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
4.21%
We expand SG&A while AVGO cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.